Krystal Biotech, Inc. (KRYS)

257.18 -5.49 (-2.09%) USD  |  NASDAQ  |  Feb 20, 12:23
More

Krystal Biotech Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for KRYS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
DexCom, Inc. Upgrade
Alkermes Plc Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade